Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
HRMY
$38.12
-0.99%
HRMY · Harmony Biosciences Holdings, Inc.
$38.12
-0.38 (-0.99%)
At close · Aug 14
Market Cap
$2.22B
Shares
58.24M
All earnings calls
Earnings call · FY2026 Q1
Harmony Biosciences Holdings, Inc. Q1 FY2026 Earnings Call
Harmony Biosciences Holdings, Inc. Q1 FY2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$215.39M
+16.6% YoY
Diluted EPS
$0.55
-29.5% YoY
Gross margin
79.3%
-3.4 pp YoY
Net income
$32.49M
-28.7% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed May 7, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Net Revenues
Full Year 2026
|
at least $1B | — |
SEC filing · Item 2.02
8-K earnings release
Filed May 7, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 7, 2026 · complete as-filed document